ABSTRACT. The envelope protein (Env) of the Jaagsiekte sheep retrovirus (JSRV) is known to be a unique oncoprotein responsible for inducing ovine pulmonary adenocarcinoma (OPA). The objective of this study was to prepare a specific monoclonal antibody (mAb) against the JSRV Env protein using bioinformatic analysis. According to the structure and epitope prediction results of JSRV Env, the JSRV-Env 572-615 antigen was prepared via peptide synthesis (amino acid sequence 572-615, denoted as JSRV-Env 572-615 ). BALB/c mice were immunized to prepare the anti-JSRV-Env 572-615 mAb. Spleen cells were fused with SP2/0 myeloma cells after being screened by indirect ELISA and cloned by limiting dilution. The specificity of mAb was evaluated by western blot analysis and immunohistochemistry assays. Western blot results showed that the JSRV Env protein was able to bind to mAb with high specificity. Immunohistochemistry assays demonstrated that the mAb was able to recognize JSRV Env in adenomatous hyperplasia of the lung. Furthermore, JSRV was detected in peripheral blood leukocytes during the pre-clinical period of OPA in 2 of the 25 sheep using this newly synthesized mAb. Therefore, this mAb may be a useful tool for the detection of JSRV in sheep.
INTRODUCTION
Jaagsiekte sheep retrovirus (JSRV) is the etiologic agent of ovine pulmonary adenocarcinoma (OPA) Fan, 2001, 2003; Leroux et al., 2007) . OPA is a significant disease in many sheep-rearing countries in Europe, Africa, Asia, and the Americas (Sharp and DeMartini, 2003) . Its latent period lasts from several months to years (Griffiths et al., 2010) . Production of copious amounts of fluid from the lung is a symptom of OPA. The fluid has a frothy, clear, milky, or at times pinkish appearance, and drains from the sheep's nostrils when the sheep lowers its head and lifts its rear end (Hofacre and Fan, 2010) . However, this lung fluid is not easily observed in many cases, which makes it difficult to carry out preventive measures and control virus transmission in a timely manner. Currently, postmortem examinations and histopathological studies are considered the most reliable ways to diagnose OPA (Azizi et al., 2014) . However, these methods are limited in detecting OPA in live animals. PCR of blood samples can be employed to detect JSRV-infected cells during the pre-clinical period (González et al., 2001; Salvatori et al., 2004; Caporale et al., 2005; De Las Heras et al., 2005) . However, this method is limited in its ability to identify only a few infected animals (Lewis et al., 2011) .
Sheep are immune-tolerant of JSRV, as the structure of JSRV resembles endogenous retroviruses (Summers et al., 2002; Spencer et al., 2003) . The sheep genome contains approximately 30 copies of the endogenous retrovirus enJSRV, which is highly related to the exogenous betaretrovirus exJSRV. The amino acid and nucleotide sequence of enJSRV demonstrate 90-98 and 85-89% homology to that of exJSRV, respectively (Palmarini et al., 2000; Carlson et al., 2003; Arnaud et al., 2007) .
Some studies have reported that the enJSRV mRNA is expressed in the immune organs of fetuses and lambs (Qi et al., 2012) , which leads to the absence of JSRV-specific antibodies in infected sheep. This has restricted the development of serological diagnostic tests.
The objective of this study was to build a monoclonal antibody (mAb) against the JSRV envelope (Env) protein, and to determine its specificity. JSRV, classified as a betaretrovirus, resembles a simple retrovirus. Its genome contains essential genes of retroviruses such as gag, pro, pol, and env. The env gene encodes the surface and transmembrane domains of the Env protein, which is located at the outermost layer of the virus (Griffiths et al., 2010; Hofacre and Fan, 2010) . This domain has been shown to be the dominant oncoprotein for inducing cell transformation both in vitro (Cousens et al., 2007; Liu and Miller, 2007) and in vivo (Wootton et al., 2005; Caporale et al., 2006) . Even though exJSRV and enJSRV demonstrate 89% homology in nucleotide sequence, there are distinct differences at the 3'-end of the env gene between exJSRV and enJSRV (Bai et al., 1999; Cousens et al., 1999; Palmarini et al., 2000) . Therefore, the cytoplasmic tail of the transmembrane portion of JSRV Env (amino acid sequence 572-615, denoted as JSRV-Env 572-615 ) encoded by the sequence at the 3'-end of the env gene was used in this study for mAb synthesis. We hypothesized that the mAb designed with JSRV-Env 572-615 could be an effective method for detecting JSRV in OPA-affected animals.
MATERIAL AND METHODS

Materials
Tumoral lung tissues infected with JSRV were collected from a sheep-breeding farm in Siziwangqi of Hohhot, Inner Mongolia Province, China. Tumoral neoplasms were confirmed by autopsy, histopathological examinations, and hemi-nested PCR (González et al., 2001) . Tissue samples were placed into individual vials, immediately frozen in liquid nitrogen, and stored at -80°C for protein and DNA extraction. The adjacent areas on the same tissues were stored in 10% buffered formalin for subsequent hematoxylin-eosin (H&E) staining and immunohistochemistry. Peripheral blood leukocytes (PBLs) were collected from non-diseased sheep in OPA-affected flocks. The PBLs were isolated by centrifugation following lysis of erythrocytes. The resulting cell pellets were stored at -80°C. Negative control samples of PBLs were obtained from healthy sheep imported from Australia. These PBLs were identified with hemi-nested PCR (González et al., 2001) . Negative control samples of lung tissues were identified via histopathological examination and hemi-nested PCR (González et al., 2001 ).
Ethics statement
All animal procedures were approved by the Inner Mongolia Agriculture University Animal Care and Use Committee in accordance with the National Animal Care Standard (GB 14925-2001) . All efforts were made to minimize animal suffering.
Analysis of the JSRV Env protein
The amino acid sequence of JSRV Env (No. JQ837489) was obtained from the GenBank (http://www.ncbi.nih.gov/genbank/). The tertiary structure of JSRV Env was predicted by the iterative-TASSER (I-TASSER) approach (Yang et al., 2015) . In I-TASSER, threading and homology modeling methods were used to predict the tertiary structure. Subsequently, adjustments and compilations were conducted using the RasMol version 2.7.0.1 software (http://www.openrasmol.org/software/rasmol/README.html). The C-score was a confidence score for estimating the quality of the predicted models. The higher the C-score used in a model, the higher the confidence, and vice versa. The B-cell epitopes of the envelope protein were predicted using Bcepred and ABCpred softwares (Sollner et al., 2008) . Based on the features of the software, the thresholds for hydrophilicity, polarity, flexibility, exposed surface, accessibility, and antigenic propensity area were set at 2.0, 2.3, 1.9, 2.4, 2.0, and 1.8, respectively.
Preparation of monoclonal antibodies against JSRV-Env 572-615
According to the structure and epitope prediction results of JSRV Env, the JSRVEnv 572-615 antigen was prepared by peptide synthesis, and connected with the keyhole limpet hemocyanin (KLH) and bovine serum albumin (BSA) to improve antigenicity (Chinese Peptide Company, China). BALB/c mice (5 weeks of age) were injected subcutaneously with 100 mg KLH-JSRV-Env 572-615 peptide emulsified with isopycnic complete Freund's adjuvant in the first immunization. The incomplete Freund's adjuvant was used in the two subsequent booster shots at 2-week intervals. A final tail intravenous immunization with the KLH-JSRV-Env 572-615 peptide alone was administered 3 days before cell fusion. Splenocytes from BALB/c mice immunized with KLH-JSRV-Env 572-615 were harvested and subsequently fused with SP2/0 myeloma cells (10:1 ratio) using 50% PEG1450. The cells were cultured in DMEM containing 10% fetal calf serum and 10% HAT for 14 days. Half of this medium was replaced with fresh medium containing 10% HAT/HT at days 3, 6 and 9. Hybridoma supernatants were screened for reactivity with enzyme-linked immunosorbent assay (ELISA), and positive clones were sub-cloned three times by the limiting dilution method. The titer of the antibody was verified by ELISA. Briefly, BSA-JSRV-Env 572-615 was diluted (concentration of 0.02 mg/mL), coated on 96-well plates (100 mL/well), and stored at 4°C overnight. It was then washed four times with PBST before 200 mL 5% skim milk was added. The plate was incubated at 37°C for 1 h. After washing four times with PBST, it was kept at 37°C for another hour with 100 mL culture supernatants and ascites at different concentrations (from 1:800 to 1:12,800 and from 1:100 to 1:1,000,000, respectively). The culture supernatants and ascites of SP2/0 myeloma cells were used as negative controls. Next, 100 µL HRP-conjugated goat anti-mouse IgG (EarthOx, USA) at 1:10,000 dilution was added to the wells, and the plate was incubated at 37°C for 1 h. Freshly prepared 3, 3', 5, 5'-tetramethylbenzidine (TMB, TIANGEN, Beijin, China) solution was used as the substrate to detect peroxidase activity. Color development was terminated after 15 min using isopycnic 2 mM H 2 SO 4 . Light absorbance was measured at 450 nm using a microplate reader (Bio-Rad, Hercules, CA, USA). The absorbance values at 450 nm from serum samples of 25 healthy mice were measured to calculate the cut-off value of ELISA.
Purification and subclass identification of monoclonal antibodies against JSRVEnv 572-615
The crude ascitic fluid was collected from the peritoneal cavities of atolin primed BALB/c mice via centrifugation (4200 g for 5 min). The globulin fraction was isolated via two rounds of selective precipitation with octanoic acid (2.5% saturation) and ammonium sulfate (45% saturation). Following the final precipitation, the proteins were dissolved in pH 7.4 PBS solution. The mAbs were desalted by dialysis, and were further purified using the Protein G Spin Purification Kit (PIERCE, USA). The purified mAbs were analyzed by SDS-PAGE and stored at -80°C for further use. The subclass of mAb was determined by the Mouse Monoclonal Antibody Isotype Assay Kit (Sigma, St. Louis, MO, USA).
Western blot analysis and immunohistochemistry assay
The specificity of mAb was evaluated by western blot analysis and immunohistochemistry assay. The total protein from lung tissue of OPA-affected sheep was extracted using the total protein extraction kit (Shanghai, China). Samples were loaded on a 10% SDS-PAGE, and were transferred to a nitrocellulose membrane. For western blot analysis, membranes were successively blocked with 5% BSA at 4°C overnight. Membranes were incubated with mAb (1:600 dilution) for 1 h, washed five times with TBST, and treated with HRP-conjugated goat anti-mouse IgG (1:5000) for another hour. Following five washes with TBST, protein visualization was carried out with 3,3'-diaminobenzidine-4HCl (DAB, Max Vision TM , Fujian, China). Immunohistochemistry staining was also applied to assess the specificity of the mAb. Thick paraffin sections (4 mm) were freshly prepared with lung tissues from the JSRV-infected sheep, and were incubated in 3% hydrogen peroxide at room temperature for 20 min to block endogenous peroxidase activity. The sections were boiled in 10 mM citrate buffer, pH 6.0, for 30 min, and were blocked for 30 min with 10% bovine serum. Samples were incubated with mAb (1:600 dilution) at 4°C overnight. After five PBS washes, HRP-labeled goat anti-mouse IgG (Max Vision TM ) was used to detect immunological reactions. Normal lung tissues were used as negative control.
Detection of JSRV in non-diseased sheep from OPA-affected flocks
The PBLs of the 25 non-diseased sheep from OPA-affected flocks were isolated and stored at -80°C. For western blotting, PBLs were suspended in 2.5 mL blood with 40 mL PBS. The supernatant was loaded on 10% polyacrylamide gels, and were subsequently transferred to nitrocellulose membranes for western blotting. JSRV-positive sheep were further verified with immunohistochemistry and hemi-nested PCR. However, due to the lack of experimental appropriations, JSRV-negative sheep were only verified by hemi-nested PCR but not postmortem examination. Genomic DNA of lung tissues was extracted with the genomic DNA extraction kit according to manufacturer instructions (TIANGEN).
RESULTS
Analysis results of the JSRV Env protein
According to the information from GenBank (No. JQ837489), JSRV Env is composed of 615-amino acid residues. The tertiary structure of JSRV Env was predicted by I-TASSER. These tertiary structure results are displayed in the space-filling model illustrated in Figure 1 . The server recommended five tertiary structure models, which are all presented as space-filling models ( Figure 1A-E) . The C-score is a confidence score for estimating the quality of the predicted models, and usually ranges from -5 to 2. The C-scores of the five models were -0.45, -1.45, -3.63, -4.30, and -2.75. The higher the C-score is for a model, the higher the confidence for that specific structure. Different colors represent different secondary structures: pink, a helix; blue, b turn; yellow, β-fold, and gray, random coil. The positions 572-615 were displayed in the space-filling model ( Figure 1F-J) . Although there are differences in the five tertiary structure models, they all have open architectures based on random coils and b turns, and show good spatial flexibility, scalability, as well as accessibility.
The B-cell epitopes of the envelope protein were predicted using both the Bcepred and ABCpred programs. The prediction results of B-cell epitopes and the cytoplasmic tail are listed in Tables 1 and 2 , respectively. These predictions suggest that the cytoplasmic tail of JSRV envelope protein may be the dominant antigen-binding region.
Purification and subclass identification of the JSRV Env-specific mAb
The purification results showed that the molecular weight of the light and heavy chains were approximately 25 and 55 kDa (Figure 2A ), respectively. Purified mAbs were successfully obtained, which could meet the requirements of the follow-up experiments.
After three rounds of sub-cloning, hybridoma supernatants, which reacted with BSA-JSRV-Env 572-615 , were used to screen antibody-secreting hybridoma cells by indirect ELISA. One clone showed strong and specific reactivity to the JSRV-Env 572-615 protein, and was selected and designated as 8E5. Isotype results showed that the mAb produced by this clone (denoted as mAb 8E5) belonged to the IgG2a subtype, and the light chains were type k ( Figure 3A) . In this study, the anti-JSRV-Env 572-615 antibodies secreted by other hybridoma cells were also examined, but they all were classified as IgM (data not shown). Tertiary structure of JSRV Env was predicted by the I-TASSER online server. The server recommended five tertiary structure models, which are presented here as space-filling models (A-E). Different colors represent different secondary structures: pink, α helix; blue, β turn; yellow, β-fold; gray, random coil. These models depict the area located at positions of 572-615-amino acid residues of JSRV Env (F-J). 
Specificity determination of mAb 8E5
The titer of the mAb 8E5 was checked by indirect ELISA analysis. According to the criterion of ELISA (cut-off value = 0.128-0.143), the titer of culture supernatants and ascites were 1:6400 and 1:100,000, respectively ( Figure 3B and C) . Western blot results showed that mAb 8E5 could specifically recognize the natural precursor protein of the JSRV Env and transmembrane protein ( Figure 2B ). Immunohistochemistry was performed to assess the Dilution titers of mAb 8E5 in culture supernatants (B) and ascites (C) were 6400 and 100,000, respectively. specificity of the mAb 8E5. The results showed that positive signals were mainly present in adenomatous hyperplasia focal of the lung tissue ( Figure 4A and B) ; this was consistent with our western blot results. Normal lung tissues ( Figure 4C ) and HBsAg mAb targeted against OPA-affected lung tissue ( Figure 4D ) were used as negative controls. 
Detection of non-diseased sheep from OPA-affected flocks with mAb 8E5
The PBLs of 25 non-diseased sheep from OPA-affected flocks were detected with mAb 8E5 by western blot. Two of the 25 sheep were positive for JSRV ( Figure 5 ). These two sheep (Animal ID SZWQ1101 and SZWQ1362, respectively) were euthanized, and clinical autopsy was carried out. Lesions were found in the lungs in both JSRV-positive sheep. Lung tissue sections were probed with mAb 8E5. Tumor-like excrescences were discovered in the lung tissue where immunostaining results also indicated positive signals (Figure 6 ). The heminested PCR products (133 bp) of lung tissues were visualized by electrophoresis. Interestingly, the hemi-nested PCR of PBLs from both sheep showed negative results (Figure 7) . 
DISCUSSION
The five predicted tertiary structure models all have open architectures based on random coils and b turns. These structures showed that the JSRV-ENV 572-615 protein has good spatial flexibility, scalability, and accessibility. These characteristics were conducive to antigen-antibody binding (Sollner et al., 2008) . The bioinformatic analysis of JSRV Env provided the necessary experimental data for the identification and screening of epitopes, and could enhance the accuracy and efficacy of antibody synthesis. Based on the results of our bioinformatic analysis, the 572-615-amino acid region was selected as the candidate antigen for synthesis of the JSRV Env mAb. Results from the epitope analysis were also in agreement with the bioinformatic analysis.
A few studies have previously detected JSRV capsid protein as well as orf-x, gag and endogenous JSRV sequences in human tissues (Rocca et al., 2008) . However, there is no clear consensus on the correlation between JSRV and human lung cancer (Yousem et al., 2001; De Las Heras et al., 2007; Hopwood et al., 2010) . Interestingly, one study has reported that a subset of human lung cancers expressed an antigen that could react with a JSRV Envspecific monoclonal antibody. Furthermore, they reported that exogenous JSRV-like env and gag sequences from tumor samples can be amplified (Linnerth-Petrik et al., 2014) . In addition, a number of epidemiological studies indicated that workers in abattoirs and meat processing plants show increased risk of developing lung cancer, which may be due to exposure to oncogenic viruses such as JSRV and bovine papilloma virus in these animals (McLean and Pearce, 2004; Johnson, 1994 Johnson, , 2011 . This has led to the speculation that JSRV could be linked to a subset of human lung cancers (Sun et al., 2007) .
In this study, a JSRV Env-specific mAb (8E5) was generated using hybridoma technology. Exogenous virus-specific hemi-nested PCR in the U3 region of JSRV LTR was used to assess the lung tissue and PBLs of two possible OPA-affected sheep. Although PBL samples from these two sheep were positive for JSRV when analyzed by western blot, hemi-nested PCR results of PBLs were negative. This could be explained by the low proportion of infected cells in blood, resulting in low amount of JSRV DNA and increased DNA degradation following extraction. We did not find copious amounts of frothy liquid in the trachea, but a tiny lesion was observed on the surface of the lung. These clinical symptoms are known to be a sign of pre-clinical period of OPA. We confirmed that these two sheep have been affected by OPA, as tumor-like excrescences were observed during histopathological examination by IHC, which is the most reliable method for OPA diagnosis (Azizi et al., 2014) . The results reported here indicate that mAb could be used for detection of JSRV in PBLs of sheep during the pre-clinical period of OPA. However, it must be stated that a negative scan cannot provide a guarantee that the animal is free of JSRV infection or early OPA.
We have shown that mAb synthesized based on the anti-cytoplasmic tail (CT) of JSRV Env was specific to JSRV. This is due to the fact that the CT region is distinct different between exogenous JSRV and endogenous JSRV (Bai et al., 1999; Cousens et al., 1999; Palmarini et al., 2000) . Using anti-CT mAb as the detection antibody is important for further exploration of early differential diagnostic methods for OPA. Hence, high-throughput and next-generation etiologic detection approaches at the protein level might be helpful for investigation of OPA and JSRV-like viruses, and have profound implications for the prevention, diagnosis and therapy of such diseases.
